Detalles de la búsqueda
1.
ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.
J Cachexia Sarcopenia Muscle;
15(3): 949-962, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38533529
2.
A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies.
Oncoimmunology;
13(1): 2290787, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38170160
3.
Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology: A Subgroup Analysis of the COSMIC-311 Study.
Thyroid;
34(3): 347-359, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38062732
4.
Pralsetinib in Patients with Advanced/Metastatic Rearranged During Transfection (RET)-Altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
Thyroid;
34(1): 26-40, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009200
5.
Clinical practice consensus for the diagnosis and management of melanoma in Taiwan.
J Formos Med Assoc;
123(1): 7-15, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37690868
6.
Acrylamide, an air pollutant, enhances allergen-induced eosinophilic lung inflammation via group 2 innate lymphoid cells.
Mucosal Immunol;
17(1): 13-24, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37805143
7.
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
Cancer Discov;
14(1): 76-89, 2024 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861461
8.
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-ß monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors.
J Immunother Cancer;
11(11)2023 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38030303
9.
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer.
Br J Cancer;
129(6): 965-973, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37537253
10.
Different immune contextures underlie tumor site-specific responses to immune checkpoint blockade in esophageal cancer.
Thorac Cancer;
14(22): 2216-2221, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37340770
11.
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC.
JTO Clin Res Rep;
4(5): 100499, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37223611
12.
Optimization of 5'UTR to evade SARS-CoV-2 Nonstructural protein 1-directed inhibition of protein synthesis in cells.
Appl Microbiol Biotechnol;
107(7-8): 2451-2468, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36843199
13.
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Cancer;
129(8): 1195-1204, 2023 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36748723
14.
Solution-Processed Isoindigo- and Thienoisoindigo-Based Donor-Acceptor-Donor π-Conjugated Small Molecules: Synthesis, Morphology, Molecular Packing, and Field-Effect Transistor Characterization.
ACS Appl Mater Interfaces;
14(50): 55886-55897, 2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36508279
15.
Polyoxygenated Terpenoids and Polyketides from the Roots of Flueggea virosa and Their Inhibitory Effect against SARS-CoV-2-Induced Inflammation.
Molecules;
27(23)2022 Dec 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36500641
16.
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial.
Cancer;
128(24): 4203-4212, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259380
17.
Antiangiogenesis May Not Be a Universal Booster of EGFR Tyrosine Kinase Inhibitors.
J Thorac Oncol;
17(9): 1063-1066, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36031284
18.
Determinants of coronavirus disease 2019 infection by artificial intelligence technology: A study of 28 countries.
PLoS One;
17(8): e0272546, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36018862
19.
Multikinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global Noninterventional Study (RIFTOS MKI).
Thyroid;
32(9): 1059-1068, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35950621
20.
Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma.
Esophagus;
19(4): 693-701, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35816242